Toggle light / dark theme

Four terminal perovskite-silicon photovoltaic designs helped them in their cause.

A collaboration of researchers from various institutes in the Netherlands broke the 30 percent barrier associated with solar cells. The achievement will help uptakeworldwide solar energy and reduce our dependence on fossil fuels, an organizational press release said.

Even as governments across the world are promoting solar energy in their bid to reduce carbon emissions, the adoption of the technology has been limited by its energy conversion efficiency. Most commercially available solar panels top out at 22 percent energy conversion efficiency.

If this could be improved, it would mean that more power can be generated in the same patch of land at a lower cost per unit, increasing energy availability while reducing the end cost to customers, making it a win-win proposition.

Including decaffeinated and instant ones.

A new study conducted by Australian scientists suggests that consuming two to three cups of decaffeinated, ground, and instant coffee can lower the risk of developing cardiovascular disease and dying early.

“In this large, observational study, ground, instant, and decaffeinated coffee were associated with equivalent reductions in the incidence of cardiovascular disease and death from cardiovascular disease or any cause,” says study author Professor Peter Kistler of the Baker Heart and Diabetes Research Institute in a media release.

“The results suggest that mild to moderate intake of ground, instant, and decaffeinated coffee should be considered part of a healthy lifestyle.”

Full Story:

Are NFTs seeing a revival in different “avatars”, though?

The rage among celebrities last year, non-fungible tokens (NFTs), have been hit badly by the crypto winter and have seen sales dip by 98 percent in the eight months since January, Coin Telegraph.

How bad are trading volumes for NFTs?


Jose Martinez Calderon/iStock.

We wonder what Tesla is going to reveal.

Once again, it is that time of the year. The annual Tesla AI Day, a demonstration of the most cutting-edge technologies from all of the company’s operating divisions is tomorrow. While Tesla vehicles receive the majority of press attention, the company has a wide range of other applications and products that it is constantly developing and improving.

Tesla’s AI is growing in popularity over time and has a livestream that millions of people view.

Some people watch because they know Elon Musk’s penchant for spectacle.

In adult mice with loss of CHD8 gene function, FDA-approved drug partially restores disrupted brain cell production

CINCINNATI, Sept. 23, 2022 /PRNewswire/ — Research led by a scientist at Cincinnati Children’s who primarily studies brain tumors may open doors for improved treatment of autism.

Autism spectrum disorder (ASD) affects about one in 40 children between ages 3 and 17, according to the National Survey of Children’s Health. Those affected often experience difficulty socializing, impaired language development, repetitive behaviors, and other symptoms. Of those tested for various genes linked to the condition, nearly everyone with disruptive mutations of the gene CHD8 has autism.

The 100 MW Dalian Flow Battery Energy Storage Peak-shaving Power Station, with the largest power and capacity in the world so far, was connected to the grid in Dalian, China, on September 29, and it will be put into operation in mid-October.

This energy storage project is supported technically by Prof. Li Xianfeng’s group from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences. And the system was built and integrated by Rongke Power Co. Ltd.

The Dalian Flow Battery Energy Storage Peak-shaving Power Station was approved by the Chinese National Energy Administration in April 2016. As the first national, large-scale storage demonstration project approved, it will eventually produce 200 megawatts (MW)/800 megawatt-hours (MWh) of electricity.

Personalized Bio-Engineered Human Hearts For All — Dr. Doris A. Taylor, Ph.D., CEO, Organamet Bio Inc.


Dr. Doris A. Taylor, Ph.D. is Chief Executive Officer of Organamet Bio Inc. (https://organametbio.com/) an early phase start-up committed to saving lives and reducing the cost of healthcare for those with heart disease. Organamet has a goal is to make personalized bio-engineered human hearts, available to all who need them, within 5 years, increasing availability and access to hearts, decreasing or eliminating need for immunosuppression, reducing total lifetime transplant costs, and improving quality of life.

Dr. Taylor was previously the Director, Regenerative Medicine Research and Director, Center for Cell and Organ Biotechnology, at the Texas Heart Institute in Houston, Texas, where she worked on the integration of regenerative medicine and tissue engineering.